About erlotinib tabs
Epidermal growth factor receptor inhibitor
Used for
- Certain types of non-small-cell lung cancer
- Pancreatic cancer, combined with gemcitabine
Usual adult dose
Lung cancer: 150 mg once daily. Pancreatic cancer: 100 mg once daily with gemcitabine.
Common side effects
- Rash and dry skin
- Diarrhea, nausea, or reduced appetite
- Fatigue
- Cough or shortness of breath
Important warnings
- Can cause serious lung inflammation, liver injury, or gastrointestinal perforation.
- Seek urgent care for severe breathing problems or persistent severe diarrhea.
- Sun exposure can worsen rash; limit exposure and use protection.
- Take on an empty stomach, at least one hour before or two hours after food.
Pregnancy
May harm an unborn baby. Effective contraception is advised during treatment and for at least one month afterward.
Breastfeeding
Breastfeeding is not recommended during treatment or for two weeks after the final dose.
Interactions
- Smoking lowers erlotinib levels; avoid smoking.
- Acid-reducing medicines can lower absorption, especially proton-pump inhibitors.
- Strong CYP3A4 inhibitors or inducers can change erlotinib levels.
- Warfarin and other blood thinners may increase bleeding risk.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.